Shekhtman, Louis
Duehren, Sarah
Etzion, Ohad
Cotler, Scott J.
Dahari, Harel
Funding for this research was provided by:
NIH (R01AI144112 and R01AI146917, R01AI144112 and R01AI146917, R01AI144112 and R01AI146917, R01AI144112 and R01AI146917)
Article History
Accepted: 19 September 2023
First Online: 11 October 2023
Declarations
:
: Dr. Ohad Etzion has received consultant fees from Eiger Biopharmaceuticals, for work not related to this manuscript.
: Dr Ohad Etzion has received consultant fees from Eiger Biopharmaceuticals, for work not related to this manuscript. All other authors declare no conflicts of interest in regard to this manuscript including financial, consultant, institutional, or other relationships that might lead to bias or conflict of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.